RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International MarketsBack to the NewsroomRMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International MarketsNew NK cell platform extends RMTG's cellular-technology portfolio into immunology-adjacent applications, with an initial commercial focus on Latin America and Southeast Asia.MIAMI, FL / ACCESS Newswire/ August 24, 2026 / Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCI ...